Validation of Fibroblast Growth Factor Receptor 3 (FGFR3) as a Therapeutic Target in T(4;14) Multiple Myeloma
Main Author: | Rodrigues de Brito, Jose Luis |
---|---|
Published: |
University of Newcastle Upon Tyne
2006
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.519480 |
Similar Items
-
Evaluation of GCS-100 as a therapy for myeloma
by: Streetly, Matthew J.
Published: (2009) -
Associations of vitamin D receptor gene polymorphisms with multiple sclerosis risk, severity and spatial clustering
by: Mamutse, Godwin
Published: (2009) -
Visualisation of the electrical activities of the heart in 3D
by: El-Aff, Inhab Abdalla
Published: (2009) -
Regulation of Jamuskinases by SOCS3; implications for polycythaemia Vera
by: Simessmuth, Y.
Published: (2010) -
Effects of the Tomatine and Provax adjuvants on THP-1 : a peripheral blood CD14 separated cells
by: Mitchell, John Paul
Published: (2006)